Bacterial Test from iCubate Well-Suited for Small, Medium Labs, Study Says

Jun 29, 2018

|

Premium

NEW YORK (GenomeWeb) – Researchers from four clinical microbiology laboratories reported this month that the iC-GPC assay developed by Huntsville, Alabama-based iCubate is an accurate and reliable tool for the detection of the five most common gram-positive bacteria responsible for bloodstream infections.

Additionally, the test detects the presence of the three clinically relevant antibiotic resistance markers specific to methicillin-resistant Staphylococcus and vancomycin-resistant Enterococcus, they noted.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Breaking News

The Scan

To Explain What They Mean

The US National Institutes of Health's All of Us project awarded $4.6 million to the company Color to develop a genetic counseling resource for the program.

A Few Days

The Times of India reports on a pilot study that used genomic testing to determine whether patients had drug-resistant tuberculosis.

Slightly Larger Pool

New guidelines say that more women may benefit from genetic testing for hereditary breast or ovarian cancer, according to the Los Angeles Times.

Cell Studies Explore Microbiome Genes, Tumor Influence, More

In Cell this week: small proteins identified among human microbiome, role for tumor microbes in pancreatic cancer survival, and more.

Featured White Papers

A High-Performance Solution Combining CleanPlex OncoZoom Cancer Hotspot Panel and SOPHiA AI for Rapid Characterization of Somatic Mutations

10 Tips to Scale Your Diagnostics Business and Grow Your Test Portfolio Globally

Build vs. Buy? 6 Questions to Consider When Investigating Clinical Diagnostics Informatics Solutions

Benchmarking of the Microsart AMP Mycoplasma Kit with Products of Two Other Suppliers

Aug

22

Featured Webinar

Biobanks and the Rise of Precision Medicine: Lessons from the Estonian Biobank

This webinar will discuss how the Estonian Biobank, a cohort of more than 165,000 participants, is addressing industry challenges with data management and collaboration in the transition to precision medicine.

Aug

29

Featured Webinar

Biobanking at Scale to Support Precision Medicine

This webinar will outline how RUCDR Infinite Biologics, the world's largest university-based biorepository, has implemented workflows and processes to support precision medicine applications.

Sep

16

Featured Webinar

Using Next-Generation Sequencing to Detect Genomic Mutations in Hematologic Malignancies

This webinar will discuss a next-generation sequencing approach for detecting genomic mutations in hematologic maglignancies.

Sep

18

Featured Webinar

Highly Sensitive Structural Variant Detection for Medical Genetics: A Comparison to the Standard of Care

This webinar will outline how a team at Radboud University Medical Center is assessing ultra-long read optical mapping on the Bionano Saphyr system to replace classical cytogenetics approaches in routine testing and for the discovery of novel structural variants with potential scientific, prognostic, or therapeutic value that are missed by standard approaches.

Menu